Earnings History Data for Esperion Therapeutics, Inc. (ESPR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc. is a biopharmaceutical company. It focused on the research, development and commercialization of therapies for low-density lipoprotein cholesterol and other cardiometabolic risk factors. Esperion Therapeutics, Inc. is based in Plymouth, Michigan.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
01-11-2022 PM 7:00 AM ET
(Nov 1)
ESPR Esperion Therapeutics, Inc. 531.75 -0.81 -0.93 -2.62 Esperion Therapeutics GAAP EPS of -$0.81 beats by $0.12, revenue of $19M misses by $0.68M
[11/1/2022 7:06 AM]
8.27 0.14 
(1.73%)
8.40 0.27 
(3.32%)
3.28 - 10.83 1,937,306 1,070,000 981
02-08-2022 PM 7:00 AM ET
(Aug 2)
ESPR Esperion Therapeutics, Inc. 391.27 -1.05 -0.95 -1.67 Esperion Therapeutics GAAP EPS of -$1.05 misses by $0.13, revenue of $18.84M beats by $0.22M
[8/2/2022 7:05 AM]
5.86 0.41 
(7.52%)
5.53 0.08 
(1.47%)
3.28 - 15.89 796,405 660,000 5,046
03-05-2022 PM 7:00 AM ET
(May 3)
ESPR Esperion Therapeutics 347.00 -0.93 -0.96 0.00 Esperion Therapeutics GAAP EPS of -$0.93 beats by $0.11, revenue of $18.83M beats by $3.42M
[5/3/2022 7:13 AM]
6.53 0.80 
(13.87%)
5.77 0.04 
(0.70%)
3.28 - 26.81 2,189,262 1,263,553 2,263
22-02-2022 PM 7:00 AM ET
(Feb 22)
ESPR Esperion Therapeutics, Inc. 238.12 -1.77 -2.32 -3.89 Esperion Therapeutics GAAP EPS of -$1.77 beats by $0.52, revenue of $15.4M beats by $0.92M
[2/22/2022 7:02 AM]
4.34 0.51 
(13.15%)
3.95 0.11 
(2.86%)
3.28 - 32.00 1,967,886 1,140,000 3,152
02-11-2021 PM 7:00 AM ET
(Nov 2)
ESPR Esperion Therapeutics, Inc. 237.18 -2.62 -2.86 -3.07 Esperion Therapeutics EPS beats by $0.22, beats on revenue
[11/2/2021 7:16 AM]
10.31 0.20 
(1.98%)
10.31 0.0 
(0.00%)
7.73 - 39.49 1,283,697 1,350,000 2,122
03-08-2021 PM 7:00 AM ET
(Aug 3)
ESPR Esperion Therapeutics, Inc. 433.88 -1.67 -1.83 4.32 Esperion Therapeutics EPS beats by $0.19, misses on revenue
[8/3/2021 7:08 AM]
14.27 -0.72 
(-4.84%)
14.97 -0.02 
(-0.13%)
13.74 - 41.48 1,285,770 740,000 2,349
04-05-2021 AH 4:10 PM ET
(May 4)
ESPR Esperion Therapeutics, Inc. 774.57 -3.50 -2.08 -2.84 Esperion Therapeutics EPS misses by $0.77, misses on revenue; provides outlook
[5/4/2021 4:07 PM]
20.01 -5.58 
(-21.81%)
18.36 -7.23 
(-28.25%)
18.01 - 53.73 5,132,823 470,000 753,134
23-02-2021 AH 4:00 PM ET
(Feb 23)
ESPR Esperion Therapeutics, Inc. 764.65 -3.89 -3.76 -2.26 Esperion Therapeutics EPS misses by $0.16, misses on revenue
[2/23/2021 4:10 PM]
28.62 0.74 
(2.65%)
29.26 1.38 
(4.95%)
23.90 - 67.59 673,874 835,876 1,148
02-11-2020 AH 4:00 PM ET
(Nov 2)
ESPR Esperion Therapeutics, Inc. 872.61 -3.07 -3.52 -2.52 Esperion Therapeutics EPS beats by $0.49, misses on revenue
[11/2/2020 4:20 PM]
24.23 -4.76 
(-16.41%)
25.67 -3.32 
(-11.45%)
23.90 - 76.98 4,216,296 528,950 88,856
10-08-2020 AH 4:05 PM ET
(Aug 10)
ESPR Esperion Therapeutics, Inc. 1,070 4.32 2.13 -2.01 Esperion Therapeutics EPS beats by $2.09, beats on revenue
[8/10/2020 4:13 PM]
34.67 -2.33 
(-6.30%)
36.10 -0.90 
(-2.43%)
24.82 - 76.98 1,207,000 704,273 14,578
06-05-2020 AH ESPR Esperion Therapeutics, Inc. 1,080 -2.84 -3.14 3.07 0.0 0.0 
(0.00%)
0.0 0.0 
(0.00%)
0.0 - 0.0 0 0 0